AZD1613
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AZD1613, covering 2026-03-12 to 2026-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants. [Phase 1]